NDC50419-0191-10: DIATRIZOATE MEGLUMINE AND DIATRI.
DIATRIZOATE MEGLUMINE AND DIATRI. Key specifications include primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 MILLILITERS, active_medicament_medicinal_strength: 52.00 PERCENTAGE, W/V MEGLUMINE ACTIVE INGREDIENT AND 8.00 PERCENTAGE, W/V SODIUM ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-215-9388, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 MILLILITERS |
| active_medicament_medicinal_strength | 52.00 PERCENTAGE, W/V MEGLUMINE ACTIVE INGREDIENT AND 8.00 PERCENTAGE, W/V SODIUM ACTIVE INGREDIENT |
| NSN | 6505-01-215-9388 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 52.00 PERCENTAGE, W/V MEGLUMINE ACTIVE INGREDIENT AND 8.00 PERCENTAGE, W/V SODIUM ACTIVE INGREDIENT |